Naq Secures £2.6 Million Investment to Transform Healthcare Compliance

In a groundbreaking move, Naq, a London-based automated digital health compliance platform, has secured a substantial investment of £2.6 million to revolutionize healthcare and medical compliance across the United Kingdom and the European Union. This oversubscribed funding round attracted the attention of No Such Ventures, along with additional support from existing investors, demonstrating strong confidence in Naq’s innovative platform and its potential to transform the healthcare industry.

Founders’ Background and Vision

Naq was founded by Nadia Kadhim, a distinguished GDPR Lawyer and Forbes 30 under 30 winner, and Chris Clinton, a former NATO and BAE Systems Cyber Security expert. Their vision for Naq stems from their profound understanding of the challenges faced by companies in highly regulated sectors like healthcare, where stringent compliance and regulatory requirements often hinder the introduction of innovative solutions. They aim to streamline compliance, ensuring healthcare data is secured, saving time for organizations, and accelerating the introduction of innovative solutions to the market.

Addressing the Compliance Gap

Naq’s automated compliance platform addresses a fundamental problem in the healthcare sector, where the traditional approach to compliance has been reliant on costly consultants, adding complexity to an already demanding process. By leveraging automation, Naq simplifies compliance, ensuring healthcare data is secured, saving time for organizations, and accelerating the introduction of innovative solutions to the market.

Benefits Beyond Compliance Streamlining

In addition to streamlining compliance, Naq’s platform offers a range of benefits that enhance the healthcare ecosystem. It enables NHS trusts, government departments, and enterprise organizations to verify the compliance status of their suppliers, ensuring adherence to regulatory standards. This comprehensive approach fosters trust and confidence, facilitating collaboration and innovation.

Impressive Growth and Recognition

Naq has experienced remarkable growth, expanding by 300% over the last 12 months. Its innovative platform empowers health and medtech innovators to meet the compliance requirements necessary for operating in the healthcare sector across the UK and EU. This approach has garnered substantial recognition, including a prestigious £460,000 Smart Grant from Innovate UK, aimed at enhancing Naq’s capabilities, particularly in leveraging AI to streamline compliance for NHS suppliers.

CEO’s Perspective on the Funding Round

Nadia Kadhim, CEO and co-founder of Naq, expressed her gratitude to the investors for their continued support and belief in Naq’s mission. She emphasized the significance of this funding round in accelerating Naq’s growth across the UK and Europe, enabling further development of its category-defining automated compliance platform. Kadhim stated, “This investment is a testament to the growing demand for innovative solutions that can streamline compliance in the healthcare industry. With the support of our investors, we are poised to revolutionize healthcare compliance across the UK and EU, fostering a more efficient and effective healthcare ecosystem.”

Investor’s Confidence in Naq’s Expertise and Product

Sophie Heijenberg, investor at No Such Ventures, lauded Naq’s expertise within the compliance market, highlighting the intuitive nature of their product and the positive customer feedback it has received. She expressed excitement about joining Naq on its stellar growth trajectory, saying, “We were impressed by Naq’s deep understanding of the compliance market and their commitment to building a user-friendly product. We believe that Naq has the potential to revolutionize the way healthcare organizations approach compliance, and we are thrilled to support their journey.”

Conclusion

The £2.6 million investment secured by Naq reflects the growing demand for innovative solutions that can streamline compliance in the healthcare industry. Naq’s platform offers a comprehensive solution that addresses the challenges faced by companies in highly regulated sectors, empowering innovators to bring their solutions to market efficiently and securely. With the support of investors, Naq is poised to revolutionize healthcare compliance across the UK and EU, fostering a more efficient and effective healthcare ecosystem.

For more information on Naq and its automated digital health compliance platform, please visit their website at www.naq.com.